Core Insights - Self-assessment taxpayers in the UK overpaid £8.9 billion ($12.18 billion) in income tax last year, primarily due to the Payment on Account system which requires advance payments based on the previous year's tax bill [1][2] - Approximately 2.6 million individuals paid too much tax through self-assessment, with many potentially unaware of their eligibility for refunds [2] - HMRC does not automatically correct overpayments, requiring taxpayers to identify and apply for refunds themselves [2][4] Overpayment Causes - Common errors leading to overpayment include incorrect salary figures and failure to claim legitimate business expenses, resulting in taxation on non-existent profits [3] - Taxpayers are advised to be meticulous when completing self-assessment forms and to seek professional advice if uncertain [3] Repayment Delays - HMRC backlogs can cause significant delays in the repayment of overpaid taxes, with some taxpayers waiting 18 to 24 months for refunds [4] - It is emphasized that taxpayers must actively check their returns and follow up on potential overpayments to avoid losing out on refunds [5]

Core Insights - SellYourWay.org has released a new white paper titled "The Role of Seller Financing in Closing Deals," which provides insights into seller financing and its significance in small business sales [1] Group 1: Seller Financing Overview - Seller financing is a common practice in small business sales, often necessary as sellers rarely receive full cash payment at closing [1] - The white paper discusses how seller financing can expand the buyer pool, enhance deal quality, and facilitate successful business transitions [1] Group 2: Key Topics Covered - The white paper covers various topics including the role of advisors, risk mitigation strategies, advantages and prevalence of seller financing, and a detailed explanation of what seller financing entails [1] - Expert insights from Lauren Drummond Dale, Principal and M&A Advisor at Coastal Consultants, emphasize that seller financing is not merely a concession but a strategic tool for successful business sales [1] Group 3: Organizational Background - SellYourWay.org aims to educate small business owners about the sales process and the role of business brokers, providing resources to help prepare for successful business sales [1] - The International Business Brokers Association (IBBA), which powers SellYourWay.org, is the largest international not-for-profit association for business brokers, offering education, support, and networking opportunities [1]

Core Insights - Houlihan Lokey, Inc. has appointed Mark Ward as a Managing Director in its Business Services Group to enhance its IT services coverage in Europe [1][2] Group 1: Appointment and Role - Mark Ward will be based in the Manchester and London offices, focusing on expanding the firm's IT services coverage across Europe [2] - He will collaborate with Malte Abrams, Managing Director and Head of IT Services, Europe, to deepen sector expertise and enhance client reach [2] Group 2: Experience and Expertise - Mr. Ward brings over 14 years of investment banking and corporate finance experience, previously serving as a Managing Director at DC Advisory [3] - His expertise includes IT consulting, software development, data analytics, and managed service providers, with a strong background in executing complex M&A and corporate finance transactions [3] Group 3: Strategic Importance - The appointment is seen as a strategic move to strengthen Houlihan Lokey's European IT Services platform amid accelerating sector consolidation [4] - The firm aims to leverage Mr. Ward's extensive sector expertise to support clients in a dynamic and competitive market [4] Group 4: Business Services Group Performance - Houlihan Lokey's Business Services Group is recognized for superior service in M&A advisory, capital-raising, restructuring, and financial advisory services [4] - In 2025, the group was ranked as the No. 1 business services M&A advisor for all global transactions, completing 92 deals [4]

Core Insights - The BIOSeedin Winter Innovation Partnering Summit was held on January 11, 2026, in San Francisco, focusing on the China Asset Showcase to promote international presentation of Chinese innovative drugs and facilitate licensing cooperation [1] Group 1: Event Overview - The summit attracted over 500 industry representatives from more than 10 countries and regions, including multinational corporations, pharmaceutical and biotechnology companies, and leading investment institutions [2] - More than 300 individual meetings and 18 special tours of innovative Chinese biotechs were organized, reflecting a dynamic atmosphere of enthusiastic exchanges and strong collaboration intentions [2] Group 2: Industry Discussions - Three cross-border roundtables were held, where seasoned business development professionals and industry leaders discussed oncology, cardio-renal and metabolic diseases, and autoimmune diseases [3] - Key topics included differentiated national therapies for high-incidence cancers reshaping Chinese R&D in oncology, AI-accelerated clinical trials in cardio-renal and metabolic diseases, and multidimensional priorities for Sino-foreign cooperation in autoimmune diseases [3] - The 18 Chinese biotechs showcased high-quality assets in cutting-edge areas such as bispecific antibodies, ADCs, and molecular glues, aligning with industry hotspots and demonstrating successful R&D achievements in niche sectors [3] Group 3: Future Directions - The summit facilitated the gathering of global cutting-edge information, activated inter-regional and inter-sectoral cooperation, and created a professional bridge for the internationalization of Chinese innovative drugs [4] - BIOSeedin plans to leverage the value of its platform, organize high-quality industry events, and collaborate with global partners to explore investment opportunities and jointly shape the future of biopharmaceutical innovation [4]

Core Insights - Current geopolitical tensions are exerting pressure on the internal security of European organizations, with 84% of high-risk organizations feeling unprepared to detect and manage internal incidents according to the Insider Trend Report 2026 by Signpost Six [1][2] Group 1: Internal Risk Landscape - Internal risk has transitioned from being incidental to a fundamental risk in a world where geopolitical conflicts increasingly manifest through economic, technological, and social channels [2] - State actors, criminal networks, and activist movements are increasingly focusing on the human factor for destabilization, making it more effective and less visible than traditional cyberattacks or physical sabotage [2] Group 2: Geopolitical Developments - The rise of hybrid warfare has significantly increased internal risk, as states are showing rivalry beyond traditional military domains, making critical infrastructure and technology companies prime targets for espionage and sabotage [3] - State actors are increasingly using criminal networks as intermediaries for operations, applying extreme pressure on employees through financial temptations, threats, and blackmail [4] Group 3: Supply Chain Vulnerabilities - The globalization of supply chains has heightened organizational vulnerabilities, as access to critical systems and processes increasingly relies on third parties operating under different legal and political regimes, directly impacting daily operations amid geopolitical tensions [5] Group 4: Organizational Resilience - Technical and physical security alone is no longer sufficient; organizational resilience requires explicit risk responsibility at the administrative level and close collaboration among HR, security, risk management, and legal departments [6] - Geopolitical developments are now occurring within organizations as well as outside, and ignoring these events puts employees at risk of becoming unintentional targets [6]

Core Message - The NGO LIFE is launching its 2026 annual operation with the goal of providing 10 million meals in 30 days, emphasizing the urgency of addressing food insecurity amid escalating humanitarian crises [1][2]. Group 1: Initiative Overview - The initiative "1€ = 1 meal" allows each euro donated to provide one complete meal (breakfast + lunch) to those in need, with over 4.6 million meals distributed last year [1]. - LIFE is expanding its operation to over 10 countries in 2026, including Comoros, Ethiopia, Kenya, Mali, Niger, Senegal, Somalia, Bangladesh, France, Lebanon, Morocco, Palestine, and Sudan, aiming to alleviate the daily struggles of millions of families in extreme poverty [2]. Group 2: Community Engagement - The success of this mission relies on collective engagement and solidarity, supported by public figures such as content creator Mehdi Debbrah, comedian Samia Orosemane, and actress Adèle Exarchopoulos, alongside the community of Lifechangers [3]. - LIFE encourages individuals to join the movement and become Lifechangers to help transform hope into tangible aid [3]. Group 3: Organizational Background - Since its establishment in 2009, LIFE has operated in over 25 countries focusing on five areas: food security, health, environment, education, and access to water, having already assisted more than 15 million people [3].

bioSeedin espera contar con su presencia en la próxima conferencia para explorar oportunidades de inversión, forjar alianzas transformadoras y definir el futuro de la innovación biofarmacéutica. www.bioseedin.com [email protected] SAN FRANCISCO, 27 de enero de 2026 /PRNewswire/ -- Como evento destacado de la Semana de la Salud de J.P. Morgan, la Cumbre de Asociación para la Innovación de Invierno de BIOSeedin se celebró en San Francisco el 11 de enero de 2026. El evento se centró en el escaparate de activos ...

En outre, la mondialisation des chaînes d'approvisionnement a accru la vulnérabilité des organisations. L'accès aux systèmes et aux processus cruciaux est de plus en plus souvent confié à des tiers qui opèrent sous des régimes juridiques et politiques différents. Les tensions géopolitiques peuvent donc avoir un impact direct sur les opérations quotidiennes. Le contexte actuel montre clairement que la sécurité technique et physique ne suffit plus. La résilience organisationnelle nécessite une appropriation e ...

SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- As a spotlight event of J.P. Morgan Healthcare Week, BIOSeedin Winter Innovation Partnering Summit took place in San Francisco on January 11, 2026, centering on China Asset Showcase to build an exclusive platform for Chinese innovative drug's international roadshow and licensing cooperation, empowering Chinese biotechs to link global resources efficiently. The summit attracted over 500 industry representatives from 10+ countries and regions, gathering MNCs, lead ...

Core Insights - Alrajhi Medicine is partnering with Oracle to implement Oracle Health Foundation EHR and Oracle Fusion Cloud Applications to enhance operational efficiency and support growth in its healthcare network [1][2][4] Company Overview - Alrajhi Medicine is a private healthcare network in Saudi Arabia, part of Abdullah Sulaiman Al Rajhi Holding (ASAQ), aiming to develop a network of modern hospitals and specialized medical centers across the Kingdom [6] Technology Adoption - Alrajhi Medicine becomes the first private healthcare group in Saudi Arabia to adopt Oracle Health and Oracle Fusion Applications as a unified digital platform, integrating clinical and business operations [2][3] - The implementation of Oracle technologies will create a fully connected ecosystem across hospitals and clinics, facilitating better data sharing and decision-making [3][4] Strategic Goals - The collaboration aims to transform digital operations and improve healthcare delivery, positioning Alrajhi Medicine as a leader in smart healthcare systems within the private sector in Saudi Arabia [4][5] - The Oracle Health Foundation EHR will enhance care coordination and communication, while reducing administrative tasks for clinicians, allowing them to focus more on patient care [4] Future Growth - Oracle's solutions are designed to scale with Alrajhi Medicine's expansion, supporting continuous innovation and setting a new benchmark for intelligent healthcare in the Middle East [5]